Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD)
The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important...
Saved in:
Published in | Lipids in health and disease Vol. 16; no. 1; p. 160 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
23.08.2017
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage.
This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method.
The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio.
Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD. |
---|---|
AbstractList | The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 [+ or -] 0.31 vs 1.5 [+ or -] 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD. The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD. The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage.BACKGROUNDThe lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage.This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method.METHODSThis work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method.The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio.RESULTSThe subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio.Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD.CONCLUSIONSStarting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD. Background The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. Methods This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. Results The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 [+ or -] 0.31 vs 1.5 [+ or -] 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Conclusions Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD. Keywords: Lipidomic analysis, Fatty acids profile, NAFLD, Erythrocyte membrane, Saturation index |
ArticleNumber | 160 |
Audience | Academic |
Author | De Nunzio, Valentina Abbrescia, Daniela I. Osella, Alberto R. Mirizzi, Antonella De Leonardis, Giampiero Tutino, Valeria Giannuzzi, Vito Cozzolongo, Raffaele Franco, Isabella Intini, Vincenza Notarnicola, Maria Caruso, Maria Gabriella Bonfiglio, Caterina |
Author_xml | – sequence: 1 givenname: Maria surname: Notarnicola fullname: Notarnicola, Maria – sequence: 2 givenname: Maria Gabriella surname: Caruso fullname: Caruso, Maria Gabriella – sequence: 3 givenname: Valeria surname: Tutino fullname: Tutino, Valeria – sequence: 4 givenname: Caterina surname: Bonfiglio fullname: Bonfiglio, Caterina – sequence: 5 givenname: Raffaele surname: Cozzolongo fullname: Cozzolongo, Raffaele – sequence: 6 givenname: Vito surname: Giannuzzi fullname: Giannuzzi, Vito – sequence: 7 givenname: Valentina surname: De Nunzio fullname: De Nunzio, Valentina – sequence: 8 givenname: Giampiero surname: De Leonardis fullname: De Leonardis, Giampiero – sequence: 9 givenname: Daniela I. surname: Abbrescia fullname: Abbrescia, Daniela I. – sequence: 10 givenname: Isabella surname: Franco fullname: Franco, Isabella – sequence: 11 givenname: Vincenza surname: Intini fullname: Intini, Vincenza – sequence: 12 givenname: Antonella surname: Mirizzi fullname: Mirizzi, Antonella – sequence: 13 givenname: Alberto R. surname: Osella fullname: Osella, Alberto R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28830448$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Us9vFCEYJabG_tA_wIsh8dIepvLNDMNwMdlUqyYbPdiDN8Iw3-zSzEAFpnUv_u1lu61pjQYCBN57fPDeIdlz3iEhr4GdArTNuwilrOuCgSgY52XBnpEDqEVTcIAfe4_W--QwxkvGSiaa5gXZL9u2YnXdHpDf3-3K2cEa7RLt0QTUEakfaNRpDjpZ76h1Pf7KI8WwSevgzSZhpBNOXdAO6RD8ROPcXaJJkd7YtKa5zkKPxq_9aA0ddEobOtprDLS38e6G46-L8-WHk5fk-aDHiK_u5yNycf7x4uxzsfz26cvZYlmYumlS0UrNhCgbUbG-7FCb3GU_dDhAxesOZC8ZFzVIaHkFshFSCi5r4CA1IlZH5P1O9mruJuwNuhT0qK6CnXTYKK-tenri7Fqt_LXivGmZlFng-F4g-J8zxqQmGw2OY_4AP0cFsgIBjWjLDH27g670iMq6wWdFs4WrRfaiFFBLllGn_0Dl1uNkTbZ5sHn_CeHN4yf8qf3BygwQO4AJPsaAgzI23RmYle2ogKltaNQuNCqHRm1Do7bS8BfzQfz_nFs5psTV |
CitedBy_id | crossref_primary_10_3390_nu12030693 crossref_primary_10_1111_hepr_13571 crossref_primary_10_1016_j_metabol_2022_155200 crossref_primary_10_3390_nu10091299 crossref_primary_10_1016_j_jacl_2020_08_007 crossref_primary_10_3390_ijms22083899 crossref_primary_10_33380_2305_2066_2021_10_4_1__206_214 crossref_primary_10_3390_ijms241512074 crossref_primary_10_47093_2218_7332_2024_15_2_48_60 crossref_primary_10_3390_nu12061652 crossref_primary_10_3390_nu12113446 crossref_primary_10_3892_etm_2020_8446 crossref_primary_10_3390_nu11112744 crossref_primary_10_1016_j_psj_2022_102352 crossref_primary_10_1093_ajcn_nqab263 crossref_primary_10_3390_ijms24021739 crossref_primary_10_3390_ijms25158285 crossref_primary_10_3390_jpm14030315 crossref_primary_10_21518_ms2024_397 crossref_primary_10_3390_metabo14010054 crossref_primary_10_3390_ijms19040962 crossref_primary_10_1371_journal_pone_0279274 crossref_primary_10_3390_jcm10204673 crossref_primary_10_1186_s12864_024_10270_w |
Cites_doi | 10.1016/0009-8981(81)90235-7 10.1016/j.plefa.2012.02.009 10.1194/jlr.M700600-JLR200 10.1002/(SICI)1097-0215(19991126)83:5<585::AID-IJC2>3.0.CO;2-Z 10.3945/ajcn.111.012054 10.1093/jnci/93.14.1088 10.1016/S1665-2681(19)31182-2 10.1136/bmj.291.6489.163 10.15288/jsa.1982.43.1157 10.1016/j.jhep.2004.02.013 10.1038/bjc.1987.223 10.1016/j.jhep.2014.01.017 10.1002/hep.21874 10.1016/j.jhep.2016.05.013 10.1007/BF02139217 10.1002/hep.21763 10.2174/1574887109666141216101630 10.1016/j.amjcard.2012.04.027 10.1056/NEJM197710272971714 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2017 BioMed Central Ltd. The Author(s). 2017 |
Copyright_xml | – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: The Author(s). 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1186/s12944-017-0552-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1476-511X |
ExternalDocumentID | PMC5568099 A511271490 28830448 10_1186_s12944_017_0552_0 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GrantInformation_xml | – fundername: ; grantid: Project identification code n° 6/CE IRCCS “De Bellis” |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAHBH AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF FRP NPM PMFND 7X8 PPXIY PQGLB 5PM PJZUB |
ID | FETCH-LOGICAL-c466t-89a07726730d2beaceac9dfbef1354b19d9057419185319679975941519aeee3 |
IEDL.DBID | M48 |
ISSN | 1476-511X |
IngestDate | Thu Aug 21 14:11:26 EDT 2025 Fri Jul 11 16:47:35 EDT 2025 Tue Jun 17 21:49:27 EDT 2025 Tue Jun 10 20:08:35 EDT 2025 Wed Feb 19 02:43:05 EST 2025 Tue Jul 01 00:23:09 EDT 2025 Thu Apr 24 22:53:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Erythrocyte membrane Fatty acids profile NAFLD Lipidomic analysis Saturation index |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c466t-89a07726730d2beaceac9dfbef1354b19d9057419185319679975941519aeee3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-017-0552-0 |
PMID | 28830448 |
PQID | 1931716782 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5568099 proquest_miscellaneous_1931716782 gale_infotracmisc_A511271490 gale_infotracacademiconefile_A511271490 pubmed_primary_28830448 crossref_citationtrail_10_1186_s12944_017_0552_0 crossref_primary_10_1186_s12944_017_0552_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-8-23 2017-Aug-23 20170823 |
PublicationDateYYYYMMDD | 2017-08-23 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-8-23 day: 23 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Lipids in health and disease |
PublicationTitleAlternate | Lipids Health Dis |
PublicationYear | 2017 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | V Pala (552_CR7) 2001; 93 M Pandey (552_CR8) 2003; 1 RA Cooper (552_CR2) 1977; 297 CB Wood (552_CR11) 1985; 11 JK Yee (552_CR22) 2008; 49 SH Caldwell (552_CR19) 2004; 40 G Serviddio (552_CR6) 2016; 9 V Chajes (552_CR12) 1999; 83 HA Skinner (552_CR16) 1982; 43 A Berzigotti (552_CR14) 2014; 9 J Folch (552_CR18) 1957; 226 K Apostolov (552_CR10) 1985; 50 R Block (552_CR23) 2012; 86 NA Habib (552_CR1) 1987; 56 SB Kelly (552_CR21) 1990; 33 G Targher (552_CR26) 2016; 65 P Almeda-Valdes (552_CR13) 2015; 14 G Coviello (552_CR9) 2014; 34 JHY Wu (552_CR25) 2011; 94 T Moilanen (552_CR17) 1981; 114 RA Persad (552_CR4) 1990; 65 A Berzigotti (552_CR15) 2014; 60 CB Wood (552_CR3) 1985; 291 N Matsuzawa (552_CR20) 2007; 46 P Puri (552_CR5) 2007; 46 L Djoussè (552_CR24) 2012; 110 10521790 - Int J Cancer. 1999 Nov 26;83(5):585-90 11459870 - J Natl Cancer Inst. 2001 Jul 18;93(14):1088-95 2242696 - Dis Colon Rectum. 1990 Dec;33(12):1026-30 15030972 - J Hepatol. 2004 Apr;40(4):578-84 22417701 - Prostaglandins Leukot Essent Fatty Acids. 2012 Apr;86(4-5):175-82 327326 - N Engl J Med. 1977 Aug 18;297(7):371-7 7182675 - J Stud Alcohol. 1982 Nov;43(11):1157-70 25514917 - Rev Recent Clin Trials. 2014;9(3):170-7 22579341 - Am J Cardiol. 2012 Aug 15;110(4):539-44 27212244 - J Hepatol. 2016 Sep;65(3):589-600 4007173 - Eur J Surg Oncol. 1985 Jun;11(2):167-9 17654743 - Hepatology. 2007 Oct;46(4):1081-90 3689663 - Br J Cancer. 1987 Oct;56(4):455-8 26019047 - Ann Hepatol. 2015 Jul-Aug;14(4):567-9 25202057 - Anticancer Res. 2014 Sep;34(9):4775-9 2337746 - Br J Urol. 1990 Mar;65(3):268-70 18599738 - J Lipid Res. 2008 Oct;49(10):2124-34 3926106 - Br Med J (Clin Res Ed). 1985 Jul 20;291(6489):163-5 13428781 - J Biol Chem. 1957 May;226(1):497-509 21697077 - Am J Clin Nutr. 2011 Aug;94(2):431-8 12793905 - World J Surg Oncol. 2003 May 7;1(1):5 17929294 - Hepatology. 2007 Nov;46(5):1392-403 27639112 - Redox Biol. 2016 Oct;9:296-305 7249369 - Clin Chim Acta. 1981 Jul 18;114(1):111-6 3859340 - Blut. 1985 Jun;50(6):349-54 24486330 - J Hepatol. 2014 May;60(5):910-2 |
References_xml | – volume: 114 start-page: 111 year: 1981 ident: 552_CR17 publication-title: Clin Chim Acta doi: 10.1016/0009-8981(81)90235-7 – volume: 86 start-page: 175 year: 2012 ident: 552_CR23 publication-title: Prostagl Leuk Essen Fatty Acid doi: 10.1016/j.plefa.2012.02.009 – volume: 49 start-page: 2124 year: 2008 ident: 552_CR22 publication-title: J Lipid Res doi: 10.1194/jlr.M700600-JLR200 – volume: 11 start-page: 167 year: 1985 ident: 552_CR11 publication-title: Eur J Surg Oncol – volume: 1 start-page: 5 year: 2003 ident: 552_CR8 publication-title: World JSurgOncol – volume: 83 start-page: 585 year: 1999 ident: 552_CR12 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19991126)83:5<585::AID-IJC2>3.0.CO;2-Z – volume: 226 start-page: 497 year: 1957 ident: 552_CR18 publication-title: J BiolChem – volume: 94 start-page: 431 year: 2011 ident: 552_CR25 publication-title: Am J Clin Nutr doi: 10.3945/ajcn.111.012054 – volume: 93 start-page: 1088 year: 2001 ident: 552_CR7 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/93.14.1088 – volume: 65 start-page: 268 year: 1990 ident: 552_CR4 publication-title: Br JUrol – volume: 50 start-page: 349 year: 1985 ident: 552_CR10 publication-title: Blutalkohol – volume: 14 start-page: 567 year: 2015 ident: 552_CR13 publication-title: Annals of Hepatol doi: 10.1016/S1665-2681(19)31182-2 – volume: 291 start-page: 163 year: 1985 ident: 552_CR3 publication-title: Br Med J doi: 10.1136/bmj.291.6489.163 – volume: 43 start-page: 1157 year: 1982 ident: 552_CR16 publication-title: J Stud Alcohol doi: 10.15288/jsa.1982.43.1157 – volume: 40 start-page: 578 year: 2004 ident: 552_CR19 publication-title: JHepatol doi: 10.1016/j.jhep.2004.02.013 – volume: 56 start-page: 455 year: 1987 ident: 552_CR1 publication-title: Br J Cancer doi: 10.1038/bjc.1987.223 – volume: 60 start-page: 910 year: 2014 ident: 552_CR15 publication-title: JHepatol. doi: 10.1016/j.jhep.2014.01.017 – volume: 34 start-page: 4775 year: 2014 ident: 552_CR9 publication-title: Anticancer Res – volume: 46 start-page: 1392 year: 2007 ident: 552_CR20 publication-title: Hepatology doi: 10.1002/hep.21874 – volume: 65 start-page: 589 year: 2016 ident: 552_CR26 publication-title: J Hepatol doi: 10.1016/j.jhep.2016.05.013 – volume: 33 start-page: 1026 year: 1990 ident: 552_CR21 publication-title: Dis Colon Rectum doi: 10.1007/BF02139217 – volume: 46 start-page: 1081 year: 2007 ident: 552_CR5 publication-title: Hepathology doi: 10.1002/hep.21763 – volume: 9 start-page: 170 year: 2014 ident: 552_CR14 publication-title: Rev Rec Clin Trials doi: 10.2174/1574887109666141216101630 – volume: 110 start-page: 539 year: 2012 ident: 552_CR24 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2012.04.027 – volume: 9 start-page: 296 year: 2016 ident: 552_CR6 publication-title: RedBiol – volume: 297 start-page: 371 year: 1977 ident: 552_CR2 publication-title: N Engl J Med doi: 10.1056/NEJM197710272971714 – reference: 18599738 - J Lipid Res. 2008 Oct;49(10):2124-34 – reference: 7182675 - J Stud Alcohol. 1982 Nov;43(11):1157-70 – reference: 17929294 - Hepatology. 2007 Nov;46(5):1392-403 – reference: 25202057 - Anticancer Res. 2014 Sep;34(9):4775-9 – reference: 27212244 - J Hepatol. 2016 Sep;65(3):589-600 – reference: 13428781 - J Biol Chem. 1957 May;226(1):497-509 – reference: 26019047 - Ann Hepatol. 2015 Jul-Aug;14(4):567-9 – reference: 12793905 - World J Surg Oncol. 2003 May 7;1(1):5 – reference: 2337746 - Br J Urol. 1990 Mar;65(3):268-70 – reference: 327326 - N Engl J Med. 1977 Aug 18;297(7):371-7 – reference: 15030972 - J Hepatol. 2004 Apr;40(4):578-84 – reference: 3926106 - Br Med J (Clin Res Ed). 1985 Jul 20;291(6489):163-5 – reference: 25514917 - Rev Recent Clin Trials. 2014;9(3):170-7 – reference: 2242696 - Dis Colon Rectum. 1990 Dec;33(12):1026-30 – reference: 22417701 - Prostaglandins Leukot Essent Fatty Acids. 2012 Apr;86(4-5):175-82 – reference: 10521790 - Int J Cancer. 1999 Nov 26;83(5):585-90 – reference: 21697077 - Am J Clin Nutr. 2011 Aug;94(2):431-8 – reference: 27639112 - Redox Biol. 2016 Oct;9:296-305 – reference: 11459870 - J Natl Cancer Inst. 2001 Jul 18;93(14):1088-95 – reference: 3859340 - Blut. 1985 Jun;50(6):349-54 – reference: 22579341 - Am J Cardiol. 2012 Aug 15;110(4):539-44 – reference: 17654743 - Hepatology. 2007 Oct;46(4):1081-90 – reference: 3689663 - Br J Cancer. 1987 Oct;56(4):455-8 – reference: 24486330 - J Hepatol. 2014 May;60(5):910-2 – reference: 7249369 - Clin Chim Acta. 1981 Jul 18;114(1):111-6 – reference: 4007173 - Eur J Surg Oncol. 1985 Jun;11(2):167-9 |
SSID | ssj0020766 |
Score | 2.25209 |
Snippet | The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may... Background The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 160 |
SubjectTerms | Adult Analysis Azotemia - blood Body Mass Index Cell membranes Cholesterol, HDL - blood Chromatography, Gas Development and progression Erythrocyte Membrane - metabolism Fatty Acids - metabolism Fatty liver Female Ferritins - blood Humans Insulin - blood Liver - metabolism Male Middle Aged Non-alcoholic Fatty Liver Disease - blood Non-alcoholic Fatty Liver Disease - metabolism Physiological aspects Red blood cells Triglycerides - blood |
Title | Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD) |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28830448 https://www.proquest.com/docview/1931716782 https://pubmed.ncbi.nlm.nih.gov/PMC5568099 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OOxBfRO_8qJ5lBfELommy2U0eRKJeOYot4t1B35ZNsquFNtUmBfPi3-7MJi2tHD4IJX3Y3bDsfP1mZzID8CwKYquF1V6ibeBxrQvUg-HAy4TluQ6KLHTR8_FEnF_x0TSaHsCmvVV3gNW1rh31k7pazd_8-tm8R4F_5wQ-Fm8rtFmccimk50dR4KEHf4SGSVJDgzHfBhUCdNlFF9i8dhkVBo5j9O-pGdCOlfpbV-8Yq_1Eyh3LNLwDtztIydKWB-7CgSmP4SQt0Z1eNOw5c0me7vb8GG6Ou1j6Cfy-mH0rKVEIz5YVDj1Whi0tq6jWpyMYc7UU8cnMqqGGCnmDyJQtzAJ97NIw-jaFVeuM7nIqRle6rFyWnm7b7s5yZnVdN2xOuR-sCwWxl5N0-PnTq3twOTy7_Hjudd0YvJwLUXtxon2E4gJVQhFkqK_xlxQ2M3YQRjwbJEWC2I-j_xc7uZZJIqME8cEg0caY8D4c4hbMQ2AGQUfGfWsRHXKTk88oTCA1MlMQGhn1wN8cvsq7SuXUMGOunMcSC9WSTiHpFJFO-T14vV3yoy3T8a_JL4iiipgK35vr7ksE3B0Vw1IpgVCJriPOPN2biaKX7w0_3fCEoiHKVyvNcl0phMVUhwjhVw8etDyy3deGx3og97hnO4Eqfu-PlLPvrvI3lYtDSP_ov1c-hluBY3hUj-EpHNartXmCqKrO-nBDTmUfjtJ0dDHC_w9nky9f--6Oou_k6A9ZESXX |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+decrease+of+saturation+index+in+erythrocytes+membrane+from+subjects+with+non-alcoholic+fatty+liver+disease+%28NAFLD%29&rft.jtitle=Lipids+in+health+and+disease&rft.au=Notarnicola%2C+Maria&rft.au=Caruso%2C+Maria+Gabriella&rft.au=Tutino%2C+Valeria&rft.au=Bonfiglio%2C+Caterina&rft.date=2017-08-23&rft.pub=BioMed+Central&rft.eissn=1476-511X&rft.volume=16&rft_id=info:doi/10.1186%2Fs12944-017-0552-0&rft_id=info%3Apmid%2F28830448&rft.externalDocID=PMC5568099 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |